Alzheimer's Drug Lecanemab Wins Full FDA Approval: What to Know
Published
has received full approval from the U.S. Food and Drug Administration. • This is the first FDA-approved treatment to help slow the progression of Alzheimer’s disease. • Doctors recommend having a careful conversation with your physician about the risks and benefits. Big news in the fight against…
#fda #doctors #leqembi #acceleratedapproval #teresaburacchio #officeofneuroscience #centersformedicare #medicaidservices #cdc #iv